Polymyalgia rheumatica screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Polymyalgia rheumatica}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polymyalgia rheumatica}} | {{Polymyalgia rheumatica}} | ||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for polymyalgia rheumatica. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for polymyalgia rheumatica. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 15:02, 13 May 2018
|
Polymyalgia Rheumatica Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polymyalgia rheumatica screening On the Web |
|
American Roentgen Ray Society Images of Polymyalgia rheumatica screening |
|
Risk calculators and risk factors for Polymyalgia rheumatica screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
There is insufficient evidence to recommend routine screening for polymyalgia rheumatica.
Screening
There is insufficient evidence to recommend routine screening for polymyalgia rheumatica.